Dr. Reddy’s Laboratories Buys U.K. Dow Chemical Drug Units
This article was originally published in The Pink Sheet Daily
Executive Summary
Move bolsters India firm’s contract research capabilities.
You may also be interested in...
Dr Reddy’s Earnings Plunge On German Unit Charge, Increased Generic Competition
Indian generics marketer experienced price erosion in the U.S. in the third quarter.
Generic Giant: Dr. Reddy’s Acquires Betapharm Group
With the $576 mil. acquisition of Betapharm, Dr. Reddy’s will expand its presence in Europe.
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.